Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial
Masi, G., Salvatore, L., Boni, L., Loupakis, F., Cremolini, C., Fornaro, L., Schirripa, M., Cupini, S., Barbara, C., Safina, V., Granetto, C., Fea, E., Antonuzzo, L., Boni, C., Allegrini, G., Chiara, S., Amoroso, D., Bonetti, A., Falcone, A.
Published in Annals of oncology (01.04.2015)
Published in Annals of oncology (01.04.2015)
Get full text
Journal Article
Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord Ovest
Cremolini, C., Loupakis, F., Antoniotti, C., Lonardi, S., Masi, G., Salvatore, L., Cortesi, E., Tomasello, G., Spadi, R., Zaniboni, A., Tonini, G., Barone, C., Vitello, S., Longarini, R., Bonetti, A., D'Amico, M., Di Donato, S., Granetto, C., Boni, L., Falcone, A.
Published in Annals of oncology (01.06.2015)
Published in Annals of oncology (01.06.2015)
Get full text
Journal Article
Primary tumor sidedness and benefit from FOLFOXIRI plus bevacizumab as initial therapy for metastatic colorectal cancer. Retrospective analysis of the TRIBE trial by GONO
Cremolini, C., Antoniotti, C., Lonardi, S., Bergamo, F., Cortesi, E., Tomasello, G., Moretto, R., Ronzoni, M., Racca, P., Loupakis, F., Zaniboni, A., Tonini, G., Buonadonna, A., Marmorino, F., Allegrini, G., Granetto, C., Masi, G., Zagonel, V., Sensi, E., Fontanini, G., Boni, L., Falcone, A.
Published in Annals of oncology (01.07.2018)
Published in Annals of oncology (01.07.2018)
Get full text
Journal Article
FOLFOXIRI or FOLFOXIRI plus bevacizumab as first-line treatment of metastatic colorectal cancer: a propensity score-adjusted analysis from two randomized clinical trials
Cremolini, C., Loupakis, F., Masi, G., Lonardi, S., Granetto, C., Mancini, M.L., Chiara, S., Moretto, R., Rossini, D., Vitello, S., Allegrini, G., Tonini, G., Bergamo, F., Tomasello, G., Ronzoni, M., Buonadonna, A., Bustreo, S., Barbara, C., Boni, L., Falcone, A.
Published in Annals of oncology (01.05.2016)
Published in Annals of oncology (01.05.2016)
Get full text
Journal Article
Erratum to “Lung cancer” [Crit. Rev. Oncol./Hematol. 27 (February (2)) (1998) 133–134]
Repetto, L., Granetto, C., Venturino, A., de Pas, T., Giacone, G.
Published in Critical reviews in oncology/hematology (01.03.2020)
Published in Critical reviews in oncology/hematology (01.03.2020)
Get full text
Journal Article
Correlation between values of specific biomarkers and outcome in metastatic colorectal cancer patients treated with regorafenib
Ricci, V., Falletta, A., Granetto, C., Paccagnella, M., Abbona, A., Fea, E., Fabozzi, T., Lo Nigro, C., Merlano, M.
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial
Galli, Fabio, Di Bartolomeo, Maria, Ronzoni, Monica, Banzi, Maria, Pasini, Felice, Bozzarelli, Silvia, Ferrari, Daris, Montesarchio, Vincenzo, Mambrini, Andrea, Ciuffreda, Libero, Pusceddu, Valeria, Carlomagno, Chiara, Bidoli, Paolo, Amoroso, Domenico, Frassineti, Luca, Pastorino, Alessandro, De Stefano, Alfonso, Labianca, Roberto, Rosati, G., Montesarchio, V., Iaffaioli, R.V., Nasti, G., Daniele, B., Lonardi, S., Pella, N., Marchetti, Roma P., Romiti, A., Foa, P., Zaniboni, A., Labianca, R., Mosconi, S., Sobrero, A., Bidoli, P., Cazzaniga, M., Beretta, G.D., Corsi, D.C., Cortesi, E., Barni, S., Petrelli, F., Allione, P., D'Arco, A.M., Valmadre, G., Piazza, E., Veltri, E., Tumulo, S., Cascinu, S., Granetto, C., Giordano, M., Moroni, M., Di Seri, M., Nuzzo, A., Gori, S., Aglietta, M., Tonini, G., Benasso, M., Graiff, C., Bravi, S., Frontini, L., Rota, S., Cozzi, L., Cantore, M., Maiello, E., Cinieri, S., Romito, S., Gebbia, V., Santoro, A., Artioli, F., Mattioli, R., Contu, A., Di Costanzo, F., Leonardi, F., Passalacqua, R., Sozzi, P., D'Amico, M., Pasquini, E., Gambi, A., Faedi, M., Cruciani, G., Bajetta, E., Gianni, L., Ronzoni, M., Massidda, B., Scartozzi, M., Zampino, M.G., Bochicchio, A.M., Frustaci, S., Pavesi, L., Verusio, C., Pinotti, G., Iop, A., De Placido, S., Carlomagno, C., Adamo, V., Ficorella, C., Greco, E., Rulli, E., Galli, F., Poli, D., Porcu, L., Torri, V.
Published in European journal of cancer (1990) (01.05.2021)
Published in European journal of cancer (1990) (01.05.2021)
Get full text
Journal Article
The role of interleukin-8 (IL-8) in predicting the outcome of metastatic colorectal cancer patients treated with aflibercept in combination to FOLFIRI: the FLIBER study
D’Arcangelo, M., Buonerba, C., Avallone, A., Dazzi, C., Frassineti, G., Tamberi, S., Tassinari, D., Aprile, G., Granetto, C., Bonetti, A., Vecchiarelli, S., Cappuzzo, F.
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
Clinical impact of neutropenia and febrile neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI/bevacizumab: a pooled analysis of TRIBE and TRIBE2 studies
Rossini, D., Sbrana, A., Bergamo, F., Manai, C., Santini, D., Ghidini, M., Antoniotti, C., Moretto, R., Marmorino, F., Urbano, F., Ronzoni, M., Noventa, S., Randon, G., Carlomagno, C., Latiano, T., Cordio, S., Granetto, C., Cremolini, C., Falcone, A., Antonuzzo, A.
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
TRIBE2: A phase III, randomized strategy study by GONO in the 1st- and 2nd-line treatment of unresectable metastatic colorectal cancer (mCRC) patients (pts)
Cremolini, C., Antoniotti, C., Lonardi, S., Rossini, D., Pietrantonio, F., Cordio, S.S., Murgioni, S., Marmorino, F., Maiello, E., Passardi, A., Masi, G., Tamburini, E., Santini, D., Grande, R., Zaniboni, A., Granetto, C., Loupakis, F., Delliponti, L., Boni, L., Falcone, A.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Updated results of TRIBE2, a phase III, randomized strategy study by GONO in the 1st- and 2nd-line treatment of unresectable mCRC
Cremolini, C., Antoniotti, C., Lonardi, S., Rossini, D., Morano, F., Cordio, S., Bergamo, F., Marmorino, F., Maiello, E., Passardi, A., Masi, G., Tamburini, E., Santini, D., Grande, R., Zaniboni, A., Granetto, C., Murgioni, S., Aprile, G., Delliponti, L., Boni, L., Falcone, A.
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
P-030Tumor-infiltrating lymphocytes (TILs) density as prognostic determinant in stage II colorectal cancer
Ricci, V, Comino, A, Vivenza, D, Granetto, C, Lo Nigro, C, Ferrero, M, Merlano, M C
Published in Annals of oncology (01.06.2016)
Published in Annals of oncology (01.06.2016)
Get full text
Journal Article
The process of truth disclosure: an assessment of the results of information during the diagnostic phase in patients with cancer
Numico, G., Anfossi, M., Bertelli, G., Russi, E., Cento, G., Silvestris, N., Granetto, C., Di Costanzo, G., Occelli, M., Fea, E., Garrone, O., Gasco, M., Colantonio, I., Merlano, M.
Published in Annals of oncology (01.05.2009)
Published in Annals of oncology (01.05.2009)
Get full text
Journal Article
6085 FOLFOXIRI (irinotecan, oxaliplatin, infusional 5FU/LV) vs FOLFIRI as first-line treatment of metastatic colorectal cancer (mCRC): updated results after 5 years follow up and risk-stratified analysis
Falcone, A, Masi, G, Vasile, E, Loupakis, F, Cupini, S, Mancini, M, Granetto, C, Ribecco, A, Andreuccetti, M, Brunetti, I.M
Published in European journal of cancer supplements (2009)
Published in European journal of cancer supplements (2009)
Get full text
Journal Article
6060 KRAS and BRAF mutational analyses in a phase II trial of first-line FOLFOXIRI plus bevacizumab (BV) in metastatic colorectal cancer (mCRC) patients (pts)
Salvatore, L, Loupakis, F, Fontanini, G, Cremolini, C, Stasi, I, Fabbri, A, Ciarlo, A, Granetto, C, Basolo, F, Falcone, A
Published in European journal of cancer supplements (2009)
Published in European journal of cancer supplements (2009)
Get full text
Journal Article
P-140Correlation between values of specific biomarkers and outcome in metastatic colorectal cancer patients treated with regorafenib
Ricci, V, Falletta, A, Granetto, C, Paccagnella, M, Abbona, A, Fea, E, Fabozzi, T, Lo Nigro, C, Merlano, M
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
3022 POSTER Long-term outcome of unresectable metastatic colorectal cancer (MCRC) patients (pts) treated with first-line FOLFOXIRI followed by R0 surgical resection of metastases
Masi, G, Bursi, S, Loupakis, F, Barbara, C, Brunetti, I, Ferraldeschi, R, Evangelista, W, Chiara, S, Granetto, C, Falcone, A
Published in European journal of cancer supplements (2007)
Published in European journal of cancer supplements (2007)
Get full text
Journal Article
P-318The role of interleukin-8 (IL-8) in predicting the outcome of metastatic colorectal cancer patients treated with aflibercept in combination to FOLFIRI: the FLIBER study
D’Arcangelo, M, Buonerba, C, Avallone, A, Dazzi, C, Frassineti, G, Tamberi, S, Tassinari, D, Aprile, G, Granetto, C, Bonetti, A, Vecchiarelli, S, Cappuzzo, F
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
1950P TRANSLATE: Activation of immune response in refractory patients to standard treatment
Merlano, M.C., Paccagnella, M., Garrone, O., Falletta, A., Fea, E., Abbona, A., Lo Nigro, C., Gammaitoni, L., Vanella, P., Monteverde, M., Granetto, C., Occelli, M., Denaro, N., Merlotti, A., Reali, A., Sangiolo, D.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
Gynaecologic cancers
Repetto, L, Granetto, C, Aapro, M, Pecorelli, S
Published in Critical reviews in oncology/hematology (01.02.1998)
Published in Critical reviews in oncology/hematology (01.02.1998)
Get full text
Journal Article